VOYA INVESTMENT MANAGEMENT LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$271,585
-7.8%
21,351
+2.0%
0.00%
Q2 2023$294,666
+1.8%
20,928
+11.7%
0.00%
Q1 2023$289,440
+2.0%
18,734
+8.3%
0.00%
Q4 2022$283,629
-11.4%
17,3050.0%0.00%
Q3 2022$320,143
+40.4%
17,3050.0%0.00%
-100.0%
Q2 2022$228,000
+51.0%
17,305
+5.7%
0.00%
Q1 2022$151,000
+7.1%
16,365
+13.4%
0.00%
Q4 2021$141,000
-79.4%
14,431
-28.3%
0.00%
-100.0%
Q3 2021$685,000
-6.5%
20,139
+0.6%
0.00%0.0%
Q2 2021$733,000
-19.4%
20,020
-1.2%
0.00%
-50.0%
Q1 2021$909,000
-15.0%
20,262
+8.1%
0.00%0.0%
Q4 2020$1,069,000
+40.3%
18,737
+26.1%
0.00%0.0%
Q3 2020$762,000
-1.3%
14,858
+15.0%
0.00%0.0%
Q2 2020$772,000
+82.1%
12,920
+25.5%
0.00%
+100.0%
Q1 2020$424,000
-29.2%
10,298
+7.0%
0.00%0.0%
Q4 2019$599,000
+154.9%
9,626
+39.0%
0.00%0.0%
Q3 2019$235,0006,9230.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,086,723$85,910,00025.70%
SV Health Investors, LLC 449,951$18,525,00015.54%
Redmile Group, LLC 5,116,263$210,637,0005.90%
Eversept Partners, LP 414,081$17,047,7154.24%
Sunesis Advisors, LLC 96,299$3,965,0003.99%
Avoro Capital Advisors LLC 2,000,000$82,340,0002.78%
Opaleye Management Inc. 222,000$9,140,0002.42%
SECTORAL ASSET MANAGEMENT INC 204,059$8,401,0001.61%
Artal Group S.A. 800,000$32,936,0001.39%
Atika Capital Management LLC 141,000$5,805,0001.11%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders